Profil
Elham Hershberger worked as the President of Emh Consulting Group, Inc. from 2017 to 2020.
She was also the Head-Clinical Development at Visterra, Inc. from 2016 to 2017 and the Chief Development Officer at Invivyd, Inc. from 2020 to 2022.
Dr. Hershberger holds a doctorate degree from Ferris State University (Michigan) and an undergraduate degree from the University of Minnesota.
Anciens postes connus de Elham Hershberger
| Sociétés | Poste | Fin |
|---|---|---|
| INVIVYD, INC. | Corporate Officer/Principal | 06/12/2022 |
| Emh Consulting Group, Inc. | President | 01/10/2020 |
| VISTERRA INC | Corporate Officer/Principal | 01/07/2017 |
Formation de Elham Hershberger
| Ferris State University (Michigan) | Doctorate Degree |
| University of Minnesota | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INVIVYD, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
| Emh Consulting Group, Inc. |
